Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - Serological tests

Serological tests

Stéphane CARLIER, Prof - Jean-Marie COLET, Prof - Fabrice JOURNE, Dr - Sven SAUSSEZ, Prof- Vincent RICHARD, Dr - Camélia ROSSI, Dr

UMONS and Ambroise-Paré Hospital Mons
" Predictive plasma signature of the clinical behavior of COVID-19 patients. The clinical presentation of COVID-19 infection varies from mild to asymptomatic to pneumonia, which can be complicated by severe respiratory failure and/or cardiovascular, renal, hepatic and cutaneous involvement. The understanding of such a polymorphism is very incomplete and the prognosis is difficult. Several tracks involving inflammatory reactions are currently favored to better explain this disease. In particular, the significant increase in plasma cytokines IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A and TNFα, known as "cytokine storm", seems to be significantly associated with the ARDS and multi-organ onsets. In this context, IL6 seems to play an important role and targeted treatments against this cytokine seem promising. Also, the infection of endothelial cells by the coronavirus causing endothelium inflammation have been suggested as one of the fundamental...

Stéphanie Roosa, Program Leader Biotechnology - Thomas Godfroid, Scientific Leader Plasma Technology - Marie-Eve Druart, Scientific Leader Wet Coatings

Materia Nova
" Based on its expertise on surface treatments and biotechnology, Materia Nova is actively working on the development of decontamination process or anti-viral surface treatments. On the one one hand, plasma technology can be used to decontaminate surfaces or fabric, like sanitary masks. Beyond masks, this technique can be used for the sterilization of medical parts (respirator tubing, surgical instruments...) even sensitive to temperature. The technology can be declined in the form of a small system that could also be useful in structures other than hospitals such as nursing homes, shops... On the other hand, the knowledge of Materia Nova in wet and dry functional coatings dedicated to various properties and applications (transport, health, energy,…) helps to investigate the anti-viral surface treatment. Due to this large panel of technologies (plasma deposition, sol-gel, organic coating or electrodeposition), the coatings or the combination of coatings can be applied on...

Thomas Michiels, Professor

UCLouvain
" On the one hand, we are developing a safe, middle throughput seroneutralization assay to correlate standard serology to seroneutralization and to enable vaccine response analysis. On the other hand, we develop a basic research project on the identification of a promising drug target site in the RNA-dependent RNA polymerase of positive-stranded RNA viruses, conserved in SARS-CoV-2. During researches performed in the framework of an EOS program, we seredendipitously discovered a conserved region of viral RNA-dependent RNA-polymerases that has properties to be targetable by drugs. This site appears to be conserved in several viruses including SARS-CoV-2 and other important human pathogens. In collaboration with a swiss group working on coronaviruses and other partners, we plan to examine the impact of this polymerase target site on the replication of several viruses, its drugability and the reason for its conservation during evolution. "
Funding: - contribution to a small...

Vincent Raussens, FNRS Senior Research Associate - Ivan Jabin, Doctor - Gilles Bruylants, Doctor - Pascale Blond

ULB - FNRS
" Germanium is widely used for attenuated total reflection (ATR) Fourier infrared transform spectroscopy (FTIR). We developed a simple way using calixarenes to functionalize these Ge surfaces and transform them in high quality and sensitive biosensors. The detection being done by ATR-FTIR allows the high sensitivity but also can quantify different molecular species in a mixture as well as their different secondary structures, both being extremely important for epidemiology study (it has been demonstrated that FTIR can discriminate different Ig proteins in a mixture). The recording of the spectra takes only few seconds and their analysis can be easily automatized. Furthermore, our laboratory is equipped for rapid and high-throughput analysis (fabrication of protein micro-arrays, infrared microscope able to record hundreds of spectra simultaneously, …). This new generation of biosensor has also the great advantage of being extremely stable and recyclable . All these...

Vincent Raussens, FNRS Senior Research Associate - Pascale Blond - Olivier Denis, Doctor

ULB and Sciensano - FNRS
" La spectroscopie IR fournit des signatures spectroscopiques spécifiques permettant une détection rapide de biomolécules dans un échantillon complexe, tout en ne requérant que très peu de matériel. La création d'un biosenseur basé sur cette méthode et appliqué aux anticorps contre le SARS-COV-2, permettrait d'étudier de manière beaucoup plus sensible, spécifique et quantitative les réponses immunologiques de la population contre le SARS-COV-2 que les tests sérologiques actuels. C'est un enjeu majeur pour gérer la période de déconfinement. "
Funding: Demande en attente auprès de l'AUF
Contact: Vincent Raussens Senior Research Associate (FRS-FNRS Belgium) Université libre de Bruxelles Structure and Function of Biological Membranes bd. du Triomphe, Access 2 - 1050 Brussels, Belgium T : +32 (0)2 650 53 86 This email address is being protected from spambots. You need JavaScript enabled to view it.

Yves BEGUIN, Professor

ULiège - Royal Academy of Medicine of Belgium
" In the context of the COVID-19 pandemic, this project involves collecting samples of human bodily material (HBM) for research projects aimed at better understanding and fighting this disease. 1 / Collection of blood and respiratory HBM from 500 patients with COVID-19 virus infection, as well as of post-mortem kidney and lung biopsies. 2 / Collection of blood HBM from 4000 healthy hospital and university staff members, currently not infected with the SARS-CoV2 virus, but possibly previously infected. SARS-CoV2 serology will be measured at 3 time points during the pandemia. "
Funding: Fondation Léon Frédéricq Wallonia Region ULiège CHU Liège
Contact: Pascale Huynen, Dpt of Microbiology, CHU of Liège. Stéphanie Gofflot, BHUL (CHU of Liège biobank).

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11

info@COVID19-WB.be

Brussels & Wallonia against COVID19